Sustained Hyperglycemia Drives Hepatic Metabolic Rewiring and Is Selectively Modulated by a Probiotic Strain in a Chicken Embryo Model of GDM

preprint OA: closed
Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-15

This study established a chicken embryo model to show sustained hyperglycemia induces hepatic metabolic rewiring and that live <italic>Leuconostoc pseudomesenteroides</italic> MLS3 selectively modulates these changes, normalizing signaling, reducing lipogenesis, and enhancing beta-oxidation and gluconeogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-15 · read from full text

The preprint studied how sustained hyperglycemia affects embryo-intrinsic hepatic metabolic programming and whether the probiotic Leuconostoc pseudomesenteroides (MLS3) can modulate these effects in a placenta-independent in ovo chicken embryo gestational diabetes mellitus (GDM) model. Using repeated D-glucose air-sack administration from embryonic day 4–18, the authors found elevated circulating glucose with reduced embryonic mass, increased relative liver weight, hepatic lipidosis, and transcriptomic evidence of a dual high-flux metabolic state involving oxidative phosphorylation, glycolysis/gluconeogenesis, and pyruvate metabolism, along with upregulation of LDHA and PCK1. Co-administration of live MLS3 most strongly reduced systemic glycemia and produced immunometabolic and mitochondrial “rescue” features (e.g., normalization of TLR2/TLR4 signaling, decreased lipogenesis, restored β-oxidation, and enhanced gluconeogenesis), whereas heat-inactivated MLS3 gave only partial glycemic benefit and retained glycolytic/lipogenic signatures with a stress-skewed transcriptome; a key caveat is that this is an avian embryo model and the work is a non–peer-reviewed preprint. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Background Gestational diabetes mellitus (GDM) exposes developing embryos to sustained hyperglycemia, yet dissecting embryo‑intrinsic mechanisms remains difficult in mammalian models due to maternal and placental influences. To directly evaluate hyperglycemia‑driven metabolic programming and probiotic modulation, we established a placenta‑independent in ovo chicken embryo model and tested the probiotic Leuconostoc pseudomesenteroides (MLS3) in live and heat‑inactivated (HI) forms. Methods and results Sustained hyperglycemia was induced by repeated air‑sac administration of D‑glucose from embryonic day (ED) 4–18, elevating circulating glucose, reducing embryonic mass, and increasing relative liver weight. Co‑administration of MLS3 attenuated systemic glycemia in a form‑dependent manner, with live MLS3 producing the greatest reduction, and preserved overall growth. Histological evaluation showed hepatic lipidosis and treatment‑specific glycogen accumulation without necroinflammation. Despite steatogenic features, hepatic SOD1 expression and malondialdehyde concentrations remained unchanged, consistent with an ED18 metabolic reliance on β‑oxidation and strong antioxidant buffering. Transcriptomic profiling revealed broad perturbations in oxidative phosphorylation, glycolysis/gluconeogenesis, and pyruvate metabolism, including robust induction of LDHA and PCK1, indicating a dual high‑flux metabolic state. Probiotic effects were highly context dependent: live MLS3 with glucose normalized TLR2/TLR4 signaling, suppressed lipogenesis, restored β‑oxidation, recalibrated ATP‑synthase stoichiometry, and markedly enhanced gluconeogenesis. HI MLS3 conferred partial glycemic benefit but maintained glycolytic and lipogenic signatures with a stress‑skewed transcriptome. Conclusion This embryo‑intrinsic model identifies a hyperglycemia‑induced dual metabolic program and demonstrates that live MLS3 elicits coordinated immunometabolic and mitochondrial rescue. These findings support strain‑informed probiotic strategies and provide a tractable platform for mechanistic studies preceding mammalian GDM models.
Full text 14,986 characters · extracted from preprint-html · click to expand
Sustained Hyperglycemia Drives Hepatic Metabolic Rewiring and Is Selectively Modulated by a Probiotic Strain in a Chicken Embryo Model of GDM | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Sustained Hyperglycemia Drives Hepatic Metabolic Rewiring and Is Selectively Modulated by a Probiotic Strain in a Chicken Embryo Model of GDM Sanya Boby, Jiddu Joseph, Erin Brannick, Shankumar Mooyottu, Muhammed Shafeekh Muyyarikkandy This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8831316/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background Gestational diabetes mellitus (GDM) exposes developing embryos to sustained hyperglycemia, yet dissecting embryo‑intrinsic mechanisms remains difficult in mammalian models due to maternal and placental influences. To directly evaluate hyperglycemia‑driven metabolic programming and probiotic modulation, we established a placenta‑independent in ovo chicken embryo model and tested the probiotic Leuconostoc pseudomesenteroides (MLS3) in live and heat‑inactivated (HI) forms. Methods and results Sustained hyperglycemia was induced by repeated air‑sac administration of D‑glucose from embryonic day (ED) 4–18, elevating circulating glucose, reducing embryonic mass, and increasing relative liver weight. Co‑administration of MLS3 attenuated systemic glycemia in a form‑dependent manner, with live MLS3 producing the greatest reduction, and preserved overall growth. Histological evaluation showed hepatic lipidosis and treatment‑specific glycogen accumulation without necroinflammation. Despite steatogenic features, hepatic SOD1 expression and malondialdehyde concentrations remained unchanged, consistent with an ED18 metabolic reliance on β‑oxidation and strong antioxidant buffering. Transcriptomic profiling revealed broad perturbations in oxidative phosphorylation, glycolysis/gluconeogenesis, and pyruvate metabolism, including robust induction of LDHA and PCK1, indicating a dual high‑flux metabolic state. Probiotic effects were highly context dependent: live MLS3 with glucose normalized TLR2/TLR4 signaling, suppressed lipogenesis, restored β‑oxidation, recalibrated ATP‑synthase stoichiometry, and markedly enhanced gluconeogenesis. HI MLS3 conferred partial glycemic benefit but maintained glycolytic and lipogenic signatures with a stress‑skewed transcriptome. Conclusion This embryo‑intrinsic model identifies a hyperglycemia‑induced dual metabolic program and demonstrates that live MLS3 elicits coordinated immunometabolic and mitochondrial rescue. These findings support strain‑informed probiotic strategies and provide a tractable platform for mechanistic studies preceding mammalian GDM models. Animal Science Endocrinology & Metabolism General Microbiology GDM Hyperglycemia chicken embryo model leaky gut metabolic reprogramming Full Text Additional Declarations The authors declare potential competing interests as follows: A provisional patent application covering the isolated probiotic strain Leuconostoc pseudomesenteroides MLS3, and its functional applications has been filed and is currently pending. The experiments described in this study were conducted using chicken embryos harvested on Embryonic Day 18 (E18). According to the guidelines set forth by the Institutional Animal Care and Use Committee (IACUC) and the Public Health Service (PHS) Policy, avian embryos are not considered 'live vertebrate animals' for the purposes of regulatory oversight until they hatch. Since all tissues were collected and experiments concluded prior to hatching (on E18), formal IACUC approval was not required for this study. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8831316","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":588348354,"identity":"a628e754-2508-4b83-8dd6-ee319f2b7ab8","order_by":0,"name":"Sanya Boby","email":"","orcid":"","institution":"University of Delaware","correspondingAuthor":false,"prefix":"","firstName":"Sanya","middleName":"","lastName":"Boby","suffix":""},{"id":588348355,"identity":"a653f21d-59a0-49b5-9828-1794ee3a0f23","order_by":1,"name":"Jiddu Joseph","email":"","orcid":"","institution":"University of Delaware","correspondingAuthor":false,"prefix":"","firstName":"Jiddu","middleName":"","lastName":"Joseph","suffix":""},{"id":588348356,"identity":"87ce6cae-6cf6-40db-a391-90024a66b1b3","order_by":2,"name":"Erin Brannick","email":"","orcid":"","institution":"University of Delaware","correspondingAuthor":false,"prefix":"","firstName":"Erin","middleName":"","lastName":"Brannick","suffix":""},{"id":588348357,"identity":"7d97ccb4-f114-436b-8aaa-397e5071800d","order_by":3,"name":"Shankumar Mooyottu","email":"","orcid":"","institution":"Auburn University","correspondingAuthor":false,"prefix":"","firstName":"Shankumar","middleName":"","lastName":"Mooyottu","suffix":""},{"id":588348358,"identity":"e97d5394-b0bc-4359-a9f9-1804bf1db5f7","order_by":4,"name":"Muhammed Shafeekh Muyyarikkandy","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAnElEQVRIiWNgGAWjYHACxgcMbAwyQIYB0VqYDYBaeEjSwiZBmhbd/tNp1TxlNjwM7M3bJIjSYnYjd9ttnnNpPAw8x8qI1cK77TZv22EeBokcMyK1nD+7rZi37T8Pg/wbYrUcyN3GzNt2AGgLD7FabuRulpxzLpmHjSet2IJYh2388KbMTo6f/fDGG0RpgQM20pSPglEwCkbBKMALAAaWJ+YRVYTuAAAAAElFTkSuQmCC","orcid":"https://orcid.org/0000-0003-3405-5440","institution":"University of Delaware","correspondingAuthor":true,"prefix":"","firstName":"Muhammed","middleName":"Shafeekh","lastName":"Muyyarikkandy","suffix":""}],"badges":[],"createdAt":"2026-02-09 14:03:18","currentVersionCode":1,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":true,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-8831316/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8831316/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":102369806,"identity":"9f316058-fbcc-48cc-878b-ea3e552508e1","added_by":"auto","created_at":"2026-02-11 03:36:09","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":7289209,"visible":true,"origin":"","legend":"","description":"","filename":"GDMManuscriptPreprint.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8831316/v1_covered_cbbbb310-6146-446f-bb3c-1b3a0b644788.pdf"}],"financialInterests":"\u003cp\u003eThe authors declare potential competing interests as follows: A provisional patent application covering the isolated probiotic strain Leuconostoc pseudomesenteroides MLS3, and its functional applications has been filed and is currently pending.\u003c/p\u003e\n\u003cp\u003eThe experiments described in this study were conducted using chicken embryos harvested on Embryonic Day 18 (E18). According to the guidelines set forth by the Institutional Animal Care and Use Committee (IACUC) and the Public Health Service (PHS) Policy, avian embryos are not considered 'live vertebrate animals' for the purposes of regulatory oversight until they hatch. Since all tissues were collected and experiments concluded prior to hatching (on E18), formal IACUC approval was not required for this study.\u003c/p\u003e","formattedTitle":"\u003cp\u003e\u003cstrong\u003eSustained Hyperglycemia Drives Hepatic Metabolic Rewiring and Is Selectively Modulated by a Probiotic Strain in a Chicken Embryo Model of GDM\u003c/strong\u003e\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"University of Delaware","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"GDM, Hyperglycemia, chicken embryo model, leaky gut, metabolic reprogramming","lastPublishedDoi":"10.21203/rs.3.rs-8831316/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8831316/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eGestational diabetes mellitus (GDM) exposes developing embryos to sustained hyperglycemia, yet dissecting embryo‑intrinsic mechanisms remains difficult in mammalian models due to maternal and placental influences. To directly evaluate hyperglycemia‑driven metabolic programming and probiotic modulation, we established a placenta‑independent \u003cem\u003ein ovo\u003c/em\u003e chicken embryo model and tested the probiotic \u003cem\u003eLeuconostoc pseudomesenteroides\u003c/em\u003e (MLS3) in live and heat‑inactivated (HI) forms.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods and results\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSustained hyperglycemia was induced by repeated air‑sac administration of D‑glucose from embryonic day (ED) 4–18, elevating circulating glucose, reducing embryonic mass, and increasing relative liver weight. Co‑administration of MLS3 attenuated systemic glycemia in a form‑dependent manner, with live MLS3 producing the greatest reduction, and preserved overall growth. Histological evaluation showed hepatic lipidosis and treatment‑specific glycogen accumulation without necroinflammation. Despite steatogenic features, hepatic SOD1 expression and malondialdehyde concentrations remained unchanged, consistent with an ED18 metabolic reliance on β‑oxidation and strong antioxidant buffering. Transcriptomic profiling revealed broad perturbations in oxidative phosphorylation, glycolysis/gluconeogenesis, and pyruvate metabolism, including robust induction of LDHA and PCK1, indicating a dual high‑flux metabolic state. Probiotic effects were highly context dependent: live MLS3 with glucose normalized TLR2/TLR4 signaling, suppressed lipogenesis, restored β‑oxidation, recalibrated ATP‑synthase stoichiometry, and markedly enhanced gluconeogenesis. HI MLS3 conferred partial glycemic benefit but maintained glycolytic and lipogenic signatures with a stress‑skewed transcriptome.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis embryo‑intrinsic model identifies a hyperglycemia‑induced dual metabolic program and demonstrates that live MLS3 elicits coordinated immunometabolic and mitochondrial rescue. These findings support strain‑informed probiotic strategies and provide a tractable platform for mechanistic studies preceding mammalian GDM models.\u003c/p\u003e","manuscriptTitle":"Sustained Hyperglycemia Drives Hepatic Metabolic Rewiring and Is Selectively Modulated by a Probiotic Strain in a Chicken Embryo Model of GDM","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-02-11 03:35:47","doi":"10.21203/rs.3.rs-8831316/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"e58741c5-10c9-4b64-943f-94d41a111bd5","owner":[],"postedDate":"February 11th, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":62592540,"name":"Animal Science"},{"id":62592541,"name":"Endocrinology \u0026 Metabolism"},{"id":62592542,"name":"General Microbiology"}],"tags":[],"updatedAt":"2026-02-11T03:35:47+00:00","versionOfRecord":[],"versionCreatedAt":"2026-02-11 03:35:47","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8831316","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8831316","identity":"rs-8831316","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00